Biotechnology Companies à University of Calgary, Calgary, AB
Trouvez des données précises sur les meilleures entreprises de la catégorie Biotechnology Companies à Calgary. Voir les avis et les coordonnées de chaque entreprise, y compris numéro de téléphone, adresse, heures d'ouverture, promotions et d'autres informations.
Affichage des résultats: 1 - 1 sur 1
Affichage des résultats: 1 - 1 sur 1
Résultats à proximité dans la catégorie Biotechnology Companies à University of Calgary, Calgary
Fermé maintenant
2500 University Drive Nw, UNIVERSITY HEIGHTS, Calgary, T2N 1N4
(403) 220-5261
Department of Biological Sciences are a community of scholars who share a commitment to insightful, innovative and integrative research in diverse areas of life sciences, from biomolecules to the biosphere, and to the development of future leaders in the basic and applied biosciences. The USC is specially equipped to answer students' questions about science programs Résultats à proximité dans la catégorie Biotechnology Companies
Fermé maintenant
3415 A, 3 Ave NW, Calgary, T2N 0M4
(587) 975-8850
Medical laboratory, Medical Lab, Biotechnology company, Laboratory, Medical Research Center 
Fermé maintenant
707 7 Ave SW #1210, Calgary, T2P 3H6
(403) 200-0424
Biotechnology company 
Suite 202 – 1201 5th Street SW, Calgary, T2L 1Y8
(403) 910-5140
Biotechnology company 
Fermé maintenant
606 Meredith Rd NE, Calgary, T2E 5A8
Simplicity is the ultimate sophistication. We believe the biggest healthcare problems can be solved by simple solutions. Our products are always simple. Clean care is safe care. We are committed to developing products that enable the clean administration of healthcare for patients and practitioners alike. Healthcare is under immense cost pressure. We create products that directly save hospitals money, thereby empowering re-investment in patient care. 
Fermé maintenant
300, 4820 Richard Road Sw, Calgary, T3E 6L1
403.254.9252
Resverlogix Corp. (TSX: RVX) is developing apabetalone (RVX-208), a first-in-class, small molecule selective BET bromodomain inhibitor. Apabetalone is the only selective BET bromodomain inhibitor in clinical trials. BET bromodomain inhibition is an epigenetic mechanism that can turn disease-causing genes off, returning them to a healthier state. Apabetalone is the first and only BET inhibitor selective for BRD4-BD2, producing a nexus of biological effects with potentially important benefits for patients with diseases such as cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, Orphan diseases (PNH), and Alzheimer's disease, while maintaining a well described safety profile. Resverlogix has commenced a Phase 3 clinical trial in CVD patients with type 2 DM and low HDL, with a primary endpoint of time to first occurrence of Major Adverse Cardiac Events (MACE). 
300, 4820 Richard Road SW, Calgary, T3E 6L1
(587) 390-7865
Biotechnology company 
Fermé maintenant
419 Manitou Road SE, HIGHLAND PARK, Calgary, T2Z 3W4
(403) 453-0233
Gas and Oil Development and Exploration 
